NYAS Conferences
New York Academy of Sciences
left end
Search
divider divider feedback right end
Annals of the New York Academy of Sciences Annals of the New York Academy of Sciences login

Main

Browse Volumes

Forthcoming Volumes

Annals PrePrints

Annals Extra

E-mail Alerts

Subscriptions & Orders

New Proposals

Author Guidelines

About Annals

Help

Get free Annals volume as a NYAS member: http://www.nyas.org/annalsreaderhw
Issue 895 coverUNCERTAINTY IN THE RISK ASSESSMENT OF ENVIRONMENTAL AND OCCUPATIONAL HAZARDS: AN INTERNATIONAL WORKSHOP Copyright © 1999 by the New York Academy of Sciences
description

This Volume
Table of Contents
Description
This Article
Full Text
Full Text (PDF)
Services
Similar articles in this journal
Similar articles in PubMed
Alert me to new issues of the journal
Download to citation manager
Citing Articles
Citing Articles via HighWire
Citing Articles via Google Scholar
Google Scholar
Articles by HUFF, J.
Search for Related Content
PubMed
PubMed Citation
Articles by HUFF, J.
Annals of the New York Academy of Sciences 895:56-79 (1999)
© 1999 New York Academy of Sciences

Long-Term Chemical Carcinogenesis Bioassays Predict Human Cancer Hazards: Issues, Controversies, and Uncertainties

JAMES HUFFa

aNational Institute of Environmental Health Sciences, Research Triangle Park, North Carolina 27709, USA

aAddress for correspondence: 919-541-3780 (voice); 919-558-7055 (fax).
e-mail: huff1{at}niehs.nih.gov

Long-term carcinogenesis bioassays are the most valued and predictive means for identifying potential carcinogenic hazards of various agents to humans. Agents may be chemicals, chemical mixtures, multiple chemicals, combinations of chemicals, residues and contaminants, commercial products and formulations, and various exposure circumstances. Life-styles, dietary factors, and occupational exposure circumstances are very difficult, but not totally impossible, to evaluate experimentally. Historically, the first chemical bioassay took place in the early part of this century: Yamagiwa and Ichikawa 1 in 1915, showed that coal tar applied experimentally to rabbit ears caused skin carcinomas. Since then, nearly 1500-2000 bioassays of one sort or another have been carried out. Importantly, however, some of these bioassays must be considered inadequate for judging the absence of carcinogenicity, since there were various limitations on the way they were performed: too few animals, too short a duration, too low exposure concentrations, too limited pathology, as examples. Thus, each bioassay must be critically evaluated, especially those reported to be negative, because "false negatives" are certainly more hazardous to human health than are "false positives". Likewise, one must be careful not to discount bioassay results simply because a target organ in rodents may not have a direct counterpart in humans (e.g., Zymbal glands 2), or because an organ site in rodents may not be a major site of cancers in humans (e.g., mouse liver). The design and conduct of a bioassay is not simple, however, and one must be fully aware of possible pitfalls as well as viable and often necessary alternatives. Similarly, evaluating results and interpreting findings must be approached with the utmost objectivity and consistency. These and other select issues, controversies, and uncertainties possibly encountered in long-term bioassays are covered in this paper. One fact remains abundantly clear: for every known human carcinogen that has been tested adequately in laboratory animals, the findings of carcinogenicity are concordant.




This article has been cited by other articles:


Home page
Hum Exp ToxicolHome page
S Hoffmann and T Hartung
Toward an evidence-based toxicology
Human and Experimental Toxicology, September 1, 2006; 25(9): 497 - 513.
[Abstract] [PDF]


Home page
BMJHome page
A. Knight, J. Bailey, J. Balcombe, W. H Farland, B. Rodan, and P. Preuss
Which drugs cause cancer? * Cancer bioassays
BMJ, October 15, 2005; 331(7521): E389 - E391.
[Full Text] [PDF]


Home page
CarcinogenesisHome page
G. Manenti and T. A. Dragani
Pas1 haplotype-dependent genetic predisposition to lung tumorigenesis in rodents: a meta-analysis
Carcinogenesis, May 1, 2005; 26(5): 875 - 882.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
J. Huff
Carcinogenicity of Bisphenol A Revisited
Toxicol. Sci., December 1, 2002; 70(2): 281 - 283.
[Full Text] [PDF]


Home page
CarcinogenesisHome page
F. Johnson and J. Huff
Development of a multi-organ rat model for evaluating chemopreventive agents: efficacy of indole-3-carbinol-Certain health supplements may cause both carcinogenic and anticarcinogenic effects
Carcinogenesis, October 1, 2002; 23(10): 1767 - 1768.
[Full Text] [PDF]


Home page
Toxicol PatholHome page
J. Ashby
Expectations for Transgenic Rodent Cancer Bioassay Models
Toxicol Pathol, January 1, 2001; 29(1_suppl): 177 - 182.
[Abstract] [PDF]



footerLeft footerRight